Annual EBITDA
-$23.07 M
+$98.54 M+81.03%
31 December 2023
Summary:
Bioventus annual earnings before interest, taxes, depreciation & amortization is currently -$23.07 million, with the most recent change of +$98.54 million (+81.03%) on 31 December 2023. During the last 3 years, it has fallen by -$77.38 million (-142.48%). BVS annual EBITDA is now -137.46% below its all-time high of $61.58 million, reached on 31 December 2019.BVS EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
$16.98 M
+$33.41 M+203.27%
28 September 2024
Summary:
Bioventus quarterly earnings before interest, taxes, depreciation & amortization is currently $16.98 million, with the most recent change of +$33.41 million (+203.27%) on 28 September 2024. Over the past year, it has increased by +$1.22 million (+7.77%). BVS quarterly EBITDA is now -41.83% below its all-time high of $29.18 million, reached on 31 March 2021.BVS Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
$31.93 M
+$1.22 M+3.99%
28 September 2024
Summary:
Bioventus TTM earnings before interest, taxes, depreciation & amortization is currently $31.93 million, with the most recent change of +$1.22 million (+3.99%) on 28 September 2024. Over the past year, it has increased by +$77.44 million (+170.14%). BVS TTM EBITDA is now -53.03% below its all-time high of $67.98 million, reached on 30 March 2024.BVS TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BVS EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +81.0% | +7.8% | +170.1% |
| 3 y3 years | -142.5% | +152.7% | -43.6% |
| 5 y5 years | -142.3% | +134.3% | +340.6% |
BVS EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -142.5% | +81.0% | -18.5% | +115.0% | -53.0% | +117.1% |
| 5 y | 5 years | -137.5% | +81.0% | -41.8% | +115.0% | -53.0% | +117.1% |
| alltime | all time | -137.5% | +81.0% | -41.8% | +115.0% | -53.0% | +117.1% |
Bioventus EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $16.98 M(-203.3%) | $31.93 M(+4.0%) |
| June 2024 | - | -$16.44 M(-196.4%) | $30.70 M(-54.8%) |
| Mar 2024 | - | $17.05 M(+18.9%) | $67.98 M(-394.7%) |
| Dec 2023 | -$23.07 M(-81.0%) | $14.34 M(-9.0%) | -$23.07 M(-49.3%) |
| Sept 2023 | - | $15.75 M(-24.4%) | -$45.52 M(-73.9%) |
| June 2023 | - | $20.84 M(-128.2%) | -$174.63 M(-6.6%) |
| Mar 2023 | - | -$74.00 M(+812.5%) | -$187.00 M(+54.4%) |
| Dec 2022 | -$121.61 M(-367.4%) | -$8.11 M(-92.8%) | -$121.12 M(+17.5%) |
| Sept 2022 | - | -$113.36 M(-1438.1%) | -$103.11 M(-707.8%) |
| June 2022 | - | $8.47 M(-204.3%) | $16.96 M(+2.5%) |
| Mar 2022 | - | -$8.13 M(-182.1%) | $16.55 M(-69.3%) |
| Dec 2021 | $45.48 M | $9.90 M(+47.4%) | $53.85 M(-4.9%) |
| Sept 2021 | - | $6.72 M(-16.6%) | $56.60 M(-16.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2021 | - | $8.05 M(-72.4%) | $67.38 M(+8.7%) |
| Mar 2021 | - | $29.18 M(+130.7%) | $61.98 M(+16.8%) |
| Dec 2020 | $54.31 M(-11.8%) | $12.65 M(-27.7%) | $53.05 M(-13.9%) |
| Sept 2020 | - | $17.49 M(+558.9%) | $61.60 M(+39.7%) |
| June 2020 | - | $2.65 M(-86.9%) | $44.10 M(+6.4%) |
| Mar 2020 | - | $20.25 M(-4.4%) | $41.45 M(+95.6%) |
| Dec 2019 | $61.58 M(+13.0%) | $21.19 M(+192.5%) | $21.19 M(+192.5%) |
| Dec 2018 | $54.52 M(+255.5%) | - | - |
| Mar 2016 | - | $7.25 M(-186.3%) | $7.25 M(-186.3%) |
| Dec 2015 | $15.34 M(-47.9%) | - | - |
| Mar 2015 | - | -$8.40 M | -$8.40 M |
| Dec 2014 | $29.44 M(+87.8%) | - | - |
| Dec 2013 | $15.68 M | - | - |
FAQ
- What is Bioventus annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Bioventus?
- What is Bioventus annual EBITDA year-on-year change?
- What is Bioventus quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Bioventus?
- What is Bioventus quarterly EBITDA year-on-year change?
- What is Bioventus TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Bioventus?
- What is Bioventus TTM EBITDA year-on-year change?
What is Bioventus annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of BVS is -$23.07 M
What is the all time high annual EBITDA for Bioventus?
Bioventus all-time high annual earnings before interest, taxes, depreciation & amortization is $61.58 M
What is Bioventus annual EBITDA year-on-year change?
Over the past year, BVS annual earnings before interest, taxes, depreciation & amortization has changed by +$98.54 M (+81.03%)
What is Bioventus quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of BVS is $16.98 M
What is the all time high quarterly EBITDA for Bioventus?
Bioventus all-time high quarterly earnings before interest, taxes, depreciation & amortization is $29.18 M
What is Bioventus quarterly EBITDA year-on-year change?
Over the past year, BVS quarterly earnings before interest, taxes, depreciation & amortization has changed by +$1.22 M (+7.77%)
What is Bioventus TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of BVS is $31.93 M
What is the all time high TTM EBITDA for Bioventus?
Bioventus all-time high TTM earnings before interest, taxes, depreciation & amortization is $67.98 M
What is Bioventus TTM EBITDA year-on-year change?
Over the past year, BVS TTM earnings before interest, taxes, depreciation & amortization has changed by +$77.44 M (+170.14%)